ACCESSION: MSBNK-SMB_Measured-HSA032P0187000
RECORD_TITLE: Characterized; Alanyl-Proline; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 26
COMMENT: RAW_SPEC {'RA1-pos_803': {'bp': 3510.0, 'sum': 7198.0}, 'HC13-pos_552': {'bp': 2396.0, 'sum': 4883.0}, 'HC12-pos_789': {'bp': 2287.0, 'sum': 5308.0}, 'HC11-pos_548': {'bp': 2124.0, 'sum': 7376.0}, 'RA8-pos_538': {'bp': 2032.0, 'sum': 7321.0}, 'HC14-pos_537': {'bp': 2025.0, 'sum': 5621.0}, 'RA20-pos_790': {'bp': 1953.0, 'sum': 4215.0}, 'HC12-pos_565': {'bp': 1906.0, 'sum': 4134.0}, 'HC15-pos_790': {'bp': 1242.0, 'sum': 2101.0}, 'RA3-pos_775': {'bp': 1231.0, 'sum': 2818.0}, 'RA25-pos_791': {'bp': 1189.0, 'sum': 3179.0}, 'HC5-pos_798': {'bp': 1093.0, 'sum': 2977.0}, 'RA24-pos_740': {'bp': 998.0, 'sum': 1972.0}, 'HC12-pos_767': {'bp': 970.0, 'sum': 2324.0}, 'RA26-pos_752': {'bp': 962.0, 'sum': 2169.0}, 'RA25-pos_771': {'bp': 934.0, 'sum': 1697.0}, 'HC11-pos_770': {'bp': 873.0, 'sum': 2131.0}, 'RA21-pos_593': {'bp': 826.0, 'sum': 1965.0}, 'RA24-pos_715': {'bp': 812.0, 'sum': 1753.0}, 'RA10-pos_781': {'bp': 757.0, 'sum': 1785.0}, 'HC4-pos_767': {'bp': 738.0, 'sum': 2305.0}, 'RA21-pos_757': {'bp': 691.0, 'sum': 1673.0}, 'HC21-pos_758': {'bp': 507.0, 'sum': 1291.0}, 'RA22-pos_722': {'bp': 489.0, 'sum': 1189.0}, 'RA11-pos_755': {'bp': 413.0, 'sum': 1194.0}, 'QC8-pos_763': {'bp': 398.0, 'sum': 951.0}}
COMMENT: RETENTION_TIME_STDEV 0.177
COMMENT: PRECURSOR_M/Z_RAW 187.106465
COMMENT: PRECURSOR_M/Z_STDEV 0.000601
COMMENT: PRECURSOR_IN_MS1 mz 187.107078; int 31.101; delta(ppm) 9.069155
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+DMSO+H; M+ACN+Na; mz 172.096286; int 8.967; cor 0.689
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 3.821; C8H14N2O3; [M+H]+; delta(ppm) -3.820532
COMMENT: PROPOSED_MF MS-FINDER 4.152; C8H14N2O3; [M+H]+; delta(ppm) -3.804008
COMMENT: PROPOSED_MF MS-FINDER 2.446; C4H10N8O; [M+H]+; delta(ppm) 10.547915
COMMENT: PROPOSED_MF SIRIUS5_Sirius 20.868; C8H14N2O3; [M+H]+; delta(ppm) -3.804008
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N2O3; [M+H]+; delta(ppm) -3.804008
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.452; C8H14N2O3; [M+H]+; delta(ppm) -3.804008
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.775; C6H12N5O2; [M+H]+; delta(ppm) 3.371902
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.121; C7H18N2Si2; [M+H]+; delta(ppm) -254708.970572
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.223; C6H13F3N2O; [M+H]+; delta(ppm) 9.264926
COMMENT: PROPOSED_MF SIRIUS6_Sirius -9.260; H13N9OP; [M+H]+; delta(ppm) 8.895870
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N2O3; [M+H]+; delta(ppm) -3.804008
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.571; SJWAAOAMGJMIQH-WDSKDSINSA-N; [M+H]+; CC(C(=O)OC(=O)C1CCCN1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.255; WPWUFUBLGADILS-UHFFFAOYNA-N; [M+H]+; CC(N)C(=O)N1CCCC1C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.171; FELJDCNGZFDUNR-UHFFFAOYNA-N; [M+H]+; CC(NC(=O)C1CCCN1)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.507; RXRMLOFYDLGVHX-MDOHGIEYNA-N; [M+H]+; CCOC(=O)N1CCC[C@H]1C(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.249; IZFXLIWWJCODDL-WDSKDSINSA-N; [M+H]+; N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.153; WPWUFUBLGADILS-UHFFFAOYNA-N; [M+H]+; Alanyl-Proline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.101; FELJDCNGZFDUNR-UHFFFAOYNA-N; [M+H]+; Prolyl-Alanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.965; SJWAAOAMGJMIQH-WDSKDSINSA-N; [M+H]+; [(2S)-2-aminopropanoyl] (2S)-pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.930; VOLMYNNEVGLNMS-UHFFFAOYSA-N; [M+H]+; 6-amino-2-[(1-hydroxyethylidene)amino]hex-4-enoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.818; GOIIOCZFZDAMIJ-WZTWBHKBNA-N; [M+H]+; UNPD109984
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.736; VRIHFCMDQVLUPW-UHFFFAOYSA-N; [M+H]+; 6-(hydroxymethyl)-3,6-dimethyl-3,4,5,6-tetrahydropyrimidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.695; RXRMLOFYDLGVHX-MDOHGIEYNA-N; [M+H]+; UNPD159452
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.672; IZFXLIWWJCODDL-WDSKDSINSA-N; [M+H]+; (3S)-3-[(2S)-2-amino-4-hydroxy-3-oxobutyl]pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.732; QSZKSGSXMHZCEF-UHFFFAOYSA-N; [M+H]+; N,N-bis(2-oxobutyl)nitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SJWAAOAMGJMIQH-WDSKDSINSA-N; [M+H]+; [(2S)-2-aminopropanoyl] (2S)-pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.926; WPWUFUBLGADILS-UHFFFAOYNA-N; [M+H]+; Alanyl-Proline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.842; VOLMYNNEVGLNMS-UHFFFAOYSA-N; [M+H]+; 6-amino-2-[(1-hydroxyethylidene)amino]hex-4-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.781; RXRMLOFYDLGVHX-MDOHGIEYNA-N; [M+H]+; UNPD159452
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.755; FELJDCNGZFDUNR-UHFFFAOYNA-N; [M+H]+; Prolyl-Alanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.738; IZFXLIWWJCODDL-WDSKDSINSA-N; [M+H]+; (3S)-3-[(2S)-2-amino-4-hydroxy-3-oxobutyl]pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.733; GOIIOCZFZDAMIJ-WZTWBHKBNA-N; [M+H]+; UNPD109984
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.630; VRIHFCMDQVLUPW-UHFFFAOYSA-N; [M+H]+; 6-(hydroxymethyl)-3,6-dimethyl-3,4,5,6-tetrahydropyrimidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QSZKSGSXMHZCEF-UHFFFAOYSA-N; [M+H]+; N,N-bis(2-oxobutyl)nitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; WPWUFUBLGADILS-WDSKDSINSA-N; [M+H]+; (2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.482; FELJDCNGZFDUNR-UHFFFAOYSA-N; [M+H]+; 2-(pyrrolidine-2-carbonylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; FZWUTBBNGPSHBP-LURJTMIESA-N; [M+H]+; (2S)-1-(3-aminopropanoyl)pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.267; XORIKGKTBZTHEF-UHFFFAOYSA-N; [M+H]+; N-[2-(2-oxo-1,3-oxazinan-3-yl)ethyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.258; RLZRSMJCPXRGNQ-UHFFFAOYSA-N; [M+H]+; N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.253; AQDXMNOZIQZQOM-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-3-(2-oxo-1,3-oxazolidin-3-yl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.187; HNYRNJAZRKCHSC-UHFFFAOYSA-N; [M+H]+; ethyl 2-(3-oxopiperazin-2-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.182; DUIYXFBABCZIPX-ALCCZGGFSA-N; [M+H]+; methyl (Z)-2-acetamido-3-(dimethylamino)prop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.155; LOJWUWGLJZYAOE-UHFFFAOYSA-N; [M+H]+; 2-(4-acetylpiperazin-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.149; QDBAGUYLJBESHO-LURJTMIESA-N; [M+H]+; methyl 2-[[(2S)-pyrrolidine-2-carbonyl]amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.149; PALCOTPJCVREEI-UHFFFAOYSA-N; [M+H]+; 3-(pyrrolidine-2-carbonylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; QSVNWNACIFWWIP-UHFFFAOYSA-N; [M+H]+; methyl 1-acetylpiperazine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; BMYPCLAGSPMBEJ-UHFFFAOYSA-N; [M+H]+; methyl 3-(3-amino-2-oxopyrrolidin-1-yl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; ZRXQTUVXCKSWQD-WDSKDSINSA-N; [M+H]+; methyl (2S)-2-amino-3-[(3S)-2-oxopyrrolidin-3-yl]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.112; AOQMXLKHSHYICM-UHFFFAOYSA-N; [M+H]+; ethyl 1-nitrosopiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.105; XCXXOQIGAOCJFQ-UHFFFAOYSA-N; [M+H]+; 1-(methylcarbamoyl)piperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.077; XBPFUNIGMQMISX-UHFFFAOYSA-N; [M+H]+; 4-oxo-4-piperazin-1-ylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; DRGYUAHMQCQWQJ-UHFFFAOYSA-N; [M+H]+; 4-(carbamoylamino)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; GRCMHZASUBOSKM-UHFFFAOYSA-N; [M+H]+; ethyl 2-oxo-2-piperazin-1-ylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; FGKIJORVCGGTTG-UHFFFAOYSA-N; [M+H]+; 3-(4-methylpiperazin-1-yl)-3-oxopropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.866; OJSLPVQBWUEQAM-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-oxoimidazolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; VHHMYPLTJYOOMG-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-oxoimidazolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.820; QMQFQBITGIQPDH-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-oxoimidazolidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; PXQANZCLKWEAHJ-UHFFFAOYSA-N; [M+H]+; 4-(hydrazinecarbonyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.655; URTNHOKHXSDNPS-UHFFFAOYSA-N; [M+H]+; 5-(diethoxymethyl)-3-methyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.533; QSZKSGSXMHZCEF-UHFFFAOYSA-N; [M+H]+; N,N-bis(2-oxobutyl)nitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.414; ZEEGXYVIQZEAOW-UHFFFAOYSA-N; [M+H]+; N,N-diethyl-3-hydroxy-2-nitrosobut-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -6.141; WPWUFUBLGADILS; [M+H]+; ACMC-20mfum
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.412; FELJDCNGZFDUNR; [M+H]+; prolylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.604; RXRMLOFYDLGVHX; [M+H]+; 1-Pyrrolidinecarboxylic acid, 2-(aminocarbonyl)-, ethyl ester, (S)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.997; VOLMYNNEVGLNMS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -314.029; XAZYBLFYZNUKHD; [M+H]+; (4r)-1-Acetyl-4-Hydroxy-N-Methyl-L-Prolinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -330.700; GOIIOCZFZDAMIJ; [M+H]+; ACMC-20lyrb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -353.355; XBPFUNIGMQMISX; [M+H]+; Oprea1_038089
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -359.834; PBRLRKDRWNHYMD; [M+H]+; 4-Imidazolidinebutanoicacid, 5-methyl-2-oxo- (9CI)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.807; LOJWUWGLJZYAOE; [M+H]+; 2-(4-acetylpiperazin-1-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -369.082; IJZQTCJAGLIWQW; [M+H]+; Ethyl4-hydroxyimino-1-piperidinecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -388.478; QSZKSGSXMHZCEF; [M+H]+; Bis(2-oxobutyl)nitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -405.593; FGKIJORVCGGTTG; [M+H]+; 3-(4-methylpiperazin-1-yl)-3-oxopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -417.240; IZFXLIWWJCODDL; [M+H]+; (3S)-3-[(2S)-2-amino-4-hydroxy-3-oxobutyl]pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -418.016; OJSLPVQBWUEQAM; [M+H]+; 1-Imidazolidinecarboxylic acid, 2-oxo-, 1,1-dimethylethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -445.637; ZEEGXYVIQZEAOW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -473.118; XHOMRVGIIXSPBX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -577.352; FCHUPHLUKSIOHS; [M+H]+; N-Nitroso-N-(butyl-N-butyrolactone)amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.986; WPWUFUBLGADILS; [M+H]+; ACMC-20mfum
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.075; WPWUFUBLGADILS; [M+H]+; 1-(2-aminopropanoyl)pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -293.956; RXRMLOFYDLGVHX; [M+H]+; ethyl 2-carbamoylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -347.662; FELJDCNGZFDUNR; [M+H]+; 2-[(pyrrolidin-2-yl)formamido]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -353.235; SJWAAOAMGJMIQH; [M+H]+; [(2S)-2-aminopropanoyl] (2S)-pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -396.730; XAZYBLFYZNUKHD; [M+H]+; 2-Pyrrolidinecarboxamide, 1-acetyl-4-hydroxy-N-methyl-, (2S,4S)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -397.031; WVWZICZAWWGULB; [M+H]+; 5-Amino-2-(2-oxoazetidin-1-yl)pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -401.351; VOLMYNNEVGLNMS; [M+H]+; 6-amino-2-[(1-hydroxyethylidene)amino]hex-4-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -404.833; QDBAGUYLJBESHO; [M+H]+; Methyl prolylglycinate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -404.976; XORIKGKTBZTHEF; [M+H]+; N-[2-(2-Oxo-1,3-oxazinan-3-yl)ethyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -408.666; LOJWUWGLJZYAOE; [M+H]+; 2-(4-Acetylpiperazin-1-ium-1-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.969; WPWUFUBLGADILS; [M+H]+; 1-(2-aminopropanoyl)pyrrolidine-2-carboxylic acid
COMMENT: CONFIDENCE Level 3: Tentative candidate, Alanyl-Proline, WPWUFUBLGADILS-WDSKDSINSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0028695;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C8H14N2O3
CH$EXACT_MASS: 186.100442
CH$SMILES: C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N
CH$IUPAC: InChI=1S/C8H14N2O3/c1-5(9)7(11)10-4-2-3-6(10)8(12)13/h5-6H,2-4,9H2,1H3,(H,12,13)/t5-,6-/m0/s1
CH$NAME: Alanylproline
CH$NAME: Alanyl-Proline
CH$NAME: (2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carboxylic acid
CH$LINK: INCHIKEY WPWUFUBLGADILS-WDSKDSINSA-N
CH$LINK: PUBCHEM CID:83525
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.256
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 187.107007
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-9200000000-fdbf4b02c80c3f4ebc7e
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  44.0494584 379.6031 44.049766 15.2329 132.45 0.8332 26 f{C2H6N1}/-0.39ppm,p-C6H9N1O3
  70.0650223 999.0000 70.065172 9.9622 0.00 1.0000 26 f{C4H8N1}/-1.48ppm,p-C4H7N1O3
  116.0709396 361.9492 116.071309 9.5631 96.64 0.9193 26 f{C5H10N1O2}/2.88ppm,p-C3H5N1O1
  128.9628265 64.7641 128.963275 17.5710 28.77 0.5380 21 ?
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  44.049458 379.60 379
  70.065022 999.00 999
  116.070940 361.95 361
  128.962826 64.76 64
//
